ARCHIVES

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

This article is from The Cancer Letter archive.

Vol. 36 No. 01 | January 15, 2010

Download PDF Visit The Full Archive

Related Articles

NTP Board Oks Seven Compounds For Tests

April 22, 1983

Chemical Society Designates Taxol, Camptothecin Discoveries Historic

April 25, 2003

Nine More state To Pay For Cancer Treatment Of CDC-Screened Women.

September 7, 2001

Four New Program Announcements For BRMP Trials Issued

October 22, 1982

75% Of Fed Research Funds Pay Direct Costs, Study Says.

July 28, 2000

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001